Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CS640
Cat. No.:
OB0425LY-170
Appearance:
Solid
Purity:
99.43%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
CS640 is a selective calmodulin-dependent kinase inhibitor that targeting mechanisms include pathways that affect energy metabolism and fat deposition.
Synonyms:
2388506-83-8; 2-[(3~{S})-3-Azanylpiperidin-1-yl]-4-[[2,6-di(propan-2-yl)pyridin-4-yl]amino]pyrimidine-5-carboxamide; 2-[(3S)-3-Aminopiperidin-1-yl]-4-[[2,6-di(propan-2-yl)pyridin-4-yl]amino]pyrimidine-5-carboxamide; M92
CAS No.:
2388506-83-8
Compound CID:
145946080
Formula:
C21H31N7O
Formula Weight:
397.52
Specification
Target:
CaMK; MEK; Mixed lineage kinase
Pathway:
Neuronal signaling; MAPK/ERK pathway
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
CS640 can be used for pathway analysis of energy metabolism and fat deposition.
